No profile data available.
Schrödinger, Inc. (SDGR) is a healthcare company in the medical sector application systems industry, based in New York, United States, with about 850 full-time employees.
It reported revenue of $255.87 million for fiscal year 2025, up 23.3% from fiscal year 2024, and net income of -$103.27 million. Its largest business segment, Software, brought in 78% of segment revenue in fiscal year 2025; United States was the largest region with 60%. Its market capitalization was $2.04 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Schrödinger reported $255.87 million in revenue for fiscal year 2025, up 23.3% from $207.54 million in fiscal year 2024.
Software, with $199.50 million or 78% of segment revenue in fiscal year 2025. Next: Drug Discovery (22%).
United States: 60% of revenue by region in fiscal year 2025, followed by Emea (29%).
$2.04 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (medical sector application systems) include Doximity, Inc. (DOCS), Waystar Holding Corp. (WAY), Guardian Pharmacy Services, Inc. (GRDN), Certara, Inc. (CERT).